Regulations on the Supervision and Administration of Medical Devices
Release time:
2014-07-10
Overview:
Decree No. 650 of the State Council of the People’s Republic of China
The “Regulations on the Supervision and Administration of Medical Devices” were revised and adopted at the 39th Executive Meeting of the State Council on February 12, 2014. The revised “Regulations on the Supervision and Administration of Medical Devices” are hereby promulgated and shall take effect as of June 1, 2014.
Premier Li Keqiang
March 7, 2014
Regulations on the Supervision and Administration of Medical Devices
(Promulgated by Order No. 276 of the State Council of the People’s Republic of China on January 4, 2000; amended and adopted at the 39th Executive Meeting of the State Council on February 12, 2014)
Chapter 1 General Provisions
Article 1: These Regulations are formulated to ensure the safety and effectiveness of medical devices and to safeguard human health and life safety.
Article 2: Any activities related to the research and development, production, distribution, and use of medical devices within the territory of the People’s Republic of China, as well as their supervisory management, shall comply with these Regulations.
Article 3: The food and drug administration department under the State Council is responsible for the nationwide supervision and management of medical devices. Relevant departments under the State Council shall, within their respective areas of responsibility, be responsible for the supervision and management related to medical devices.
The food and drug administration departments of local people's governments at or above the county level are responsible for the supervision and management of medical devices within their administrative jurisdictions. Relevant departments of local people's governments at or above the county level are responsible for the supervision and management related to medical devices within the scope of their respective duties.
The food and drug administration department under the State Council shall cooperate with relevant departments of the State Council to implement the national medical device industry plan and policies.
Article 4: The State shall implement classified management of medical devices according to their risk levels.
The first category comprises medical devices with low risk levels, for which routine management can ensure their safety and effectiveness.
The second category comprises medical devices that pose a moderate risk and require strict control and management to ensure their safety and effectiveness.
The third category comprises medical devices that pose a higher risk and require special measures and stringent controls to ensure their safety and effectiveness.
When assessing the risk level of a medical device, factors such as its intended purpose, structural characteristics, and method of use should be taken into consideration.
The food and drug administration department under the State Council is responsible for formulating classification rules and a classification catalog for medical devices. Based on the production, distribution, and use of medical devices, it shall promptly analyze and evaluate changes in the risks associated with these devices and adjust the classification catalog accordingly. In formulating and adjusting the classification catalog, the department shall fully solicit opinions from medical device manufacturers and operators, as well as from user institutions and industry organizations, and shall also take into account international practices in medical device classification. The classification catalog for medical devices shall be made publicly available to the public.
Article 5: The development of medical devices shall adhere to the principles of safety, effectiveness, and cost-efficiency. The State encourages research and innovation in medical devices, leverages the role of market mechanisms, promotes the dissemination and application of new medical device technologies, and fosters the development of the medical device industry.
Article 6: Medical device products shall comply with the mandatory national standards for medical devices. If there are no mandatory national standards yet, they shall comply with the mandatory industry standards for medical devices.
The catalog of single-use medical devices is formulated, adjusted, and published jointly by the State Council’s Food and Drug Administration and the State Council’s health and family planning authority. Medical devices that can be safely and effectively reused are not included in the catalog of single-use medical devices. Medical devices that, following improvements in design, manufacturing processes, or disinfection and sterilization technologies, can be safely and effectively reused should be removed from the catalog of single-use medical devices.
Article 7: Medical device industry organizations shall strengthen self-discipline within the industry, promote the development of an integrity system, urge enterprises to carry out production and business activities in compliance with the law, and guide enterprises to act with honesty and trustworthiness.
Chapter 2: Registration and Filing of Medical Device Products
Article 8: Class I medical devices shall be subject to product filing management, while Class II and Class III medical devices shall be subject to product registration management.
Article 9: For the filing of Class I medical device products and the application for registration of Class II and Class III medical device products, the following documents shall be submitted:
(1) Product risk analysis documentation;
(2) Product technical requirements;
(3) Product inspection report;
(4) Clinical evaluation data;
(5) Draft product instructions and label samples;
(6) Quality management system documents related to product development and production;
(7) Other materials required to demonstrate the safety and efficacy of the product.
The applicant and registrant of medical devices shall be responsible for the authenticity of the submitted materials.
Article 10: For the filing of Class I medical device products, the filer shall submit the filing materials to the food and drug administration department of the municipal people's government at the prefectural level where the filer is located. Among these materials, the product inspection report may be a self-inspection report prepared by the filer; clinical evaluation data, excluding clinical trial reports, may include data obtained from literature or from clinical use of similar products, demonstrating that the medical device is safe and effective.
Foreign manufacturers exporting Class I medical devices into China shall, through their representative offices established in China or through a corporate legal entity designated within China as their agent, submit registration materials and documentation certifying that the competent authority in the manufacturer’s home country (or region) has approved the medical device for marketing and sale to the Food and Drug Administration under the State Council.
If any of the items specified in the filing documents change, the entity shall submit an amendment to the original filing authority.
Article 11: To apply for registration of Class II medical device products, the applicant shall submit the registration application materials to the food and drug administration department of the people's government of the province, autonomous region, or municipality directly under the central government where the applicant is located. To apply for registration of Class III medical device products, the applicant shall submit the registration application materials to the food and drug administration department under the State Council.
Foreign manufacturers exporting Class II and Class III medical devices into China shall, through their representative offices established in China or through a corporate legal entity designated within China as their agent, submit registration application materials and documentation certifying that the competent authority in the manufacturer’s home country (or region) has approved the medical device for marketing and sale to the State Council’s Administration for Food and Drug Supervision.
For Class II and Class III medical device product registration applications, the product inspection reports submitted must be issued by a medical device testing institution. Clinical evaluation data shall include clinical trial reports, except for medical devices exempted from clinical trials pursuant to Article 17 of these Regulations.
Article 12: The food and drug administration department that accepts a registration application shall, within 3 working days from the date of acceptance, forward the registration application materials to the technical review agency. The technical review agency shall submit its review opinion to the food and drug administration department upon completion of the technical review.
Article 13: The food and drug administration department that accepts the registration application shall make a decision within 20 working days from the date of receipt of the review opinion. If the application meets the requirements for safety and effectiveness, the department shall grant registration and issue a medical device registration certificate; if the application does not meet the requirements, the department shall refuse registration and provide a written explanation of the reasons.
If the food and drug administration department of the State Council deems it necessary to verify the quality management system when organizing technical reviews of imported medical devices, it shall instruct a technical inspection agency specializing in quality management systems to conduct such a verification.
Article 14: For Class II and Class III medical device products that have already been registered, if substantial changes occur in their design, raw materials, manufacturing processes, intended use, or methods of use—changes that could potentially affect the safety and effectiveness of the medical device—the registrant shall apply to the original registration authority for amendment registration procedures. If the changes are non-substantial and do not affect the safety and effectiveness of the medical device, the registrant shall simply file a record of such changes with the original registration authority.
Article 15: The validity period of a medical device registration certificate is five years. If renewal of the registration is required upon expiration, an application for renewal shall be submitted to the original registration authority six months before the expiration date.
Except in the circumstances specified in paragraph 3 of this article, the food and drug administration department receiving an application for renewal of registration shall make a decision to approve the renewal before the expiration date of the medical device registration certificate. If no decision is made within the prescribed time limit, it shall be deemed that the renewal has been approved.
Registration shall not be renewed if any of the following circumstances apply:
(1) The registrant fails to submit an application for renewal of registration within the prescribed time limit;
(2) The mandatory standards for medical devices have been revised, and medical devices applying for registration renewal cannot meet the new requirements;
(3) For medical devices used in the treatment of rare diseases and urgently needed to respond to public health emergencies, if the items specified on the medical device registration certificate have not been completed within the prescribed time limit.
Article 16: For medical devices newly developed and not yet included in the classification catalog, the applicant may either directly apply for product registration in accordance with the provisions of this Regulation concerning the registration of Class III medical devices, or, based on the classification rules, determine the product’s classification and then apply to the State Council’s Food and Drug Administration for confirmation of its classification before proceeding with registration or product filing as prescribed in this Regulation.
For applications directly submitted for registration of Class III medical devices, the State Council’s Administration for Food and Drug Supervision shall determine the classification based on the level of risk and promptly include approved medical devices in the classification catalog. In cases where classification confirmation is requested, the State Council’s Administration for Food and Drug Supervision shall, within 20 working days from the date of receipt of the application, determine the classification of the medical device and notify the applicant accordingly.
Article 17: For Class I medical device products, registration filing does not require clinical trials. To apply for registration of Class II and Class III medical device products, clinical trials are required; however, clinical trials may be exempted under any of the following circumstances:
(1) The working mechanism is clearly defined, the design has been finalized, the production process is well-established, and the medical device of the same type that is already on the market has been clinically used for many years with no record of serious adverse events and does not alter its conventional intended use.
(2) The medical device can be demonstrated to be safe and effective through non-clinical evaluation;
(3) The safety and effectiveness of the medical device can be demonstrated by analyzing and evaluating data obtained from clinical trials or clinical use of the same type of medical device.
The catalog of medical devices exempt from clinical trials is formulated, adjusted, and published by the food and drug administration department under the State Council.
Article 18: Clinical trials of medical devices shall be conducted in qualified clinical trial institutions in accordance with the requirements of the Good Clinical Practice for Medical Device Clinical Trials, and shall be filed with the food and drug administration department of the people's government of the province, autonomous region, or municipality directly under the central government where the sponsor of the clinical trial is located. The food and drug administration department that accepts the clinical trial filing shall notify the food and drug administration department at the same level and the health and family planning authority in the location of the clinical trial institution about the filing status.
The qualification criteria for clinical trial institutions of medical devices and the Good Clinical Practice guidelines for clinical trials shall be formulated and promulgated jointly by the State Council’s Food and Drug Administration and the State Council’s health and family planning authorities. Clinical trial institutions for medical devices shall be designated and announced jointly by the State Council’s Food and Drug Administration and the State Council’s health and family planning authorities.
Article 19: Clinical trials involving Class III medical devices that pose a high risk to human subjects shall be approved by the State Council’s Administration for Market Regulation of Food and Drugs. The catalog of Class III medical devices that pose a high risk to human subjects in clinical trials shall be formulated, adjusted, and published by the State Council’s Administration for Market Regulation of Food and Drugs.
When approving clinical trials, the food and drug administration department under the State Council shall conduct a comprehensive analysis of such factors as the equipment and qualified personnel of the institutions proposed to undertake the medical device clinical trials, the risk level of the medical device in question, the clinical trial implementation plan, and the comparative analysis report on clinical benefits versus risks. If a clinical trial is approved, the applicant for the clinical trial, as well as the food and drug administration departments and health and family planning authorities of the provinces, autonomous regions, and municipalities where the clinical trial institutions are located, shall be notified accordingly.
Chapter 3: Medical Device Manufacturing
Article 20: To engage in the manufacturing of medical devices, the following conditions must be met:
(1) Possess production premises, environmental conditions, production equipment, and specialized technical personnel that are suitable for the manufacture of medical devices;
(2) An organization or dedicated inspection personnel equipped with inspection equipment for conducting quality inspections of manufactured medical devices;
(3) A management system that ensures the quality of medical devices;
(4) Possess after-sales service capabilities that are commensurate with the medical devices being manufactured;
(5) Requirements stipulated in product development and manufacturing process documentation.
Article 21: For those engaged in the production of Class I medical devices, the manufacturing enterprise shall file a record with and submit supporting documentation demonstrating compliance with the conditions stipulated in Article 20 of these Regulations to the food and drug administration department of the prefectural-level people's government where it is located.
Article 22: Manufacturers engaged in the production of Class II and Class III medical devices shall apply to the food and drug administration department of the people's government of the province, autonomous region, or municipality directly under the central government where they are located for a manufacturing license, and submit supporting documentation demonstrating that they meet the conditions stipulated in Article 20 of these Regulations, as well as the registration certificates for the medical devices they intend to manufacture.
The food and drug administration department responsible for accepting applications for manufacturing licenses shall, within 30 working days from the date of acceptance, review the application materials and conduct an inspection in accordance with the Medical Device Manufacturing Quality Management Standards formulated by the food and drug administration department under the State Council. If the application meets the prescribed conditions, the department shall grant the license and issue a medical device manufacturing license; if the application does not meet the prescribed conditions, the department shall deny the license and provide a written explanation of the reasons.
The validity period of a medical device manufacturing license is five years. If renewal is required upon expiration, the renewal procedures shall be carried out in accordance with the relevant laws and regulations governing administrative licensing.
Article 23: The Good Manufacturing Practice for Medical Devices shall clearly specify requirements concerning factors that affect the safety and effectiveness of medical devices, including the design and development of medical devices, production equipment conditions, procurement of raw materials, control of the manufacturing process, organizational structure of the enterprise, and staffing.
Article 24: Medical device manufacturers shall, in accordance with the requirements of the Medical Device Production Quality Management Regulations, establish and maintain a sound quality management system that is appropriate for the medical devices they produce and ensure its effective operation. They shall organize production strictly in compliance with the technical requirements of products that have been registered or filed, ensuring that the medical devices leaving the factory meet the mandatory standards as well as the technical requirements of the products that have been registered or filed.
Medical device manufacturers shall conduct regular self-inspections of the operation of their quality management systems and submit self-inspection reports to the food and drug administration departments of the people's governments of the provinces, autonomous regions, and municipalities directly under the central government where they are located.
Article 25: If the production conditions of a medical device manufacturer change and no longer meet the requirements of the medical device quality management system, the manufacturer shall immediately take corrective measures. If such changes could affect the safety or effectiveness of the medical devices, the manufacturer shall immediately suspend production activities and report to the food and drug administration department of the county-level people's government in its jurisdiction.
Article 26: Medical devices shall use generic names. The generic names shall comply with the naming rules for medical devices formulated by the food and drug administration department under the State Council.
Article 27: Medical devices shall be accompanied by instructions and labels. The content of the instructions and labels shall be consistent with the relevant information that has been registered or filed.
The instructions and labels for medical devices shall indicate the following items:
(1) Generic name, model, and specifications;
(2) The name and address of the manufacturing enterprise, its production address, and contact information;
(3) The identification number of the product’s technical requirements;
(4) Date of manufacture and shelf life or expiration date;
(5) Product performance, main structure, and scope of application;
(6) Contraindications, precautions, and other information requiring warnings or reminders;
(7) Installation and usage instructions or diagrams;
(8) Maintenance and care methods, special storage conditions and methods;
(9) Other contents that shall be indicated in accordance with the product technical requirements.
Class II and Class III medical devices shall also indicate the registration certificate number of the medical device, as well as the name, address, and contact information of the registrant of the medical device.
Medical devices intended for individual consumer use shall also include special instructions for safe use.
Article 28: For medical devices manufactured under contract, the commissioning party shall be responsible for the quality of the contracted medical devices. The contract manufacturer must be a medical device manufacturing enterprise that complies with the provisions of these Regulations and possesses the requisite production conditions. The commissioning party shall strengthen its management of the contract manufacturer’s production activities to ensure that such activities are carried out in accordance with statutory requirements.
Implantable medical devices with high risks may not be entrusted for manufacturing. The specific catalog shall be formulated, adjusted, and published by the food and drug administration department under the State Council.
Chapter 4: Operation and Use of Medical Devices
Article 29: Those engaged in the business activities of medical devices shall have business premises and storage conditions that are commensurate with the scale and scope of their operations, as well as a quality management system and a quality management organization or personnel that are appropriate for the medical devices they handle.
Article 30: For those engaged in the distribution of Class II medical devices, the operating enterprise shall file a record with and submit supporting documentation demonstrating compliance with the conditions set forth in Article 29 of these Regulations to the food and drug administration department of the prefectural-level people's government where the enterprise is located.
Article 31: Enterprises engaged in the distribution of Class III medical devices shall apply for an operating license from the food and drug administration department of the municipal people's government at the prefectural level where they are located, and submit supporting documentation demonstrating that they meet the conditions stipulated in Article 29 of these Regulations.
The food and drug administration department responsible for accepting applications for business licenses shall conduct a review within 30 working days from the date of acceptance and, if necessary, organize on-site inspections. If the applicant meets the prescribed conditions, the department shall grant the license and issue a medical device business license; if the applicant does not meet the prescribed conditions, the department shall deny the license and provide a written explanation of the reasons.
The validity period of the medical device business license is five years. If renewal is required upon expiration, the renewal procedures shall be carried out in accordance with the relevant laws and regulations on administrative licensing.
Article 32: Medical device operators and users purchasing medical devices shall verify the supplier’s qualifications and the qualification certificates of the medical devices, and establish a system for recording incoming inspections. Operators engaged in wholesale business of Class II and Class III medical devices, as well as retail business of Class III medical devices, shall also establish a sales record-keeping system.
The recorded items include:
(1) The name, model, specifications, and quantity of the medical device;
(2) Production batch number, expiration date, and date of sale of the medical device;
(3) Name of the manufacturing enterprise;
(4) The name, address, and contact information of the supplier or the purchaser;
(5) The numbers of relevant permit and certification documents, etc.
Records of incoming goods inspection and sales records shall be truthful and shall be retained for the periods prescribed by the food and drug administration department under the State Council. The state encourages the use of advanced technological means for record-keeping.
Article 33: The transportation and storage of medical devices shall comply with the requirements specified in the device’s instructions for use and labeling. Where special environmental conditions such as temperature and humidity are required, appropriate measures shall be taken to ensure the safety and effectiveness of the medical devices.
Article 34: Medical device users shall have storage facilities and conditions that are appropriate for the types and quantities of medical devices in use.
Medical device users shall strengthen technical training for their staff and use medical devices in accordance with the product instructions, technical operation specifications, and other relevant requirements.
Article 35: Medical device users shall handle reusable medical devices in accordance with the disinfection and management regulations formulated by the health and family planning authorities under the State Council.
Single-use medical devices must not be reused. Used devices shall be destroyed and documented in accordance with relevant national regulations.
Article 36: Medical device users shall, in accordance with the requirements specified in the product instructions, conduct inspections, tests, calibrations, maintenance, and servicing of medical devices that require regular inspection, testing, calibration, maintenance, and servicing, and shall keep records thereof. They shall promptly analyze and evaluate these records to ensure that the medical devices remain in good condition and to guarantee the quality of their use. For large-scale medical devices with long service lives, users shall establish individual usage files for each device, recording details such as its usage, maintenance, transfer, and actual operating time. The retention period for these records shall be no less than five years after the expiration of the medical device’s prescribed service life.
Article 37: Medical device users shall properly preserve the original documentation for purchased Class III medical devices and ensure that the information is traceable.
For the use of large medical devices as well as implantable and interventional medical devices, the names of the medical devices, their key technical parameters, and other essential information closely related to usage safety and quality shall be recorded in medical records and other relevant documentation.
Article 38: If a medical device in use is found to pose a safety hazard, the medical device user shall immediately cease its use and notify the manufacturer or other organization responsible for product quality to carry out repairs. Medical devices that, after repair, still fail to meet safety standards shall not be continued in use.
Article 39: The food and drug administration department and the health and family planning authority shall, according to their respective responsibilities, supervise and manage the quality of medical devices and the conduct of medical device usage in the use stage.
Article 40: Medical device operators and users shall not engage in the operation or use of medical devices that have not been legally registered, lack valid certification documents, or are expired, invalidated, or obsolete.
Article 41: When medical device users transfer in-use medical devices to each other, the transferring party shall ensure that the transferred medical devices are safe and effective, and shall not transfer medical devices that are expired, invalidated, phased out, or have failed inspection.
Article 42: Medical devices imported shall be those that have been registered or filed in accordance with the provisions of Chapter II of these Regulations.
Imported medical devices shall be accompanied by instructions and labels in Chinese. Such instructions and labels must comply with the requirements of these Regulations as well as those of relevant mandatory standards, and must clearly indicate the device’s country of origin and the name, address, and contact information of the agent. Devices without Chinese instructions or labels, or whose instructions and labels do not conform to the provisions of this Article, may not be imported.
Article 43: The inspection and quarantine authorities at ports of entry and exit shall, in accordance with the law, conduct inspections on imported medical devices. Those that fail the inspection shall not be allowed to enter the country.
The food and drug administration department under the State Council shall promptly notify the national entry-exit inspection and quarantine authorities of the registration and filing status of imported medical devices. The entry-exit inspection and quarantine agencies at the port of entry shall promptly inform the food and drug administration department of the people's government at the prefectural-level city where they are located about the customs clearance status of imported medical devices.
Article 44: Enterprises exporting medical devices shall ensure that the medical devices they export comply with the requirements of the importing country (or region).
Article 45: Medical device advertisements shall be truthful and lawful and shall not contain false, exaggerated, or misleading content.
Medical device advertisements shall be reviewed and approved by the food and drug administration department of the people's government of the province, autonomous region, or municipality directly under the central government where the medical device manufacturer or the importer’s agent is located, and must obtain an approval document for medical device advertising. Advertisers who publish medical device advertisements shall, prior to publication, verify the validity and authenticity of the advertisement’s approval document. They shall not publish medical device advertisements that have not obtained the required approval document, whose approval document has not been verified for authenticity, or whose content differs from the approved document. The food and drug administration departments of the people's governments of provinces, autonomous regions, and municipalities directly under the central government shall publicly announce and promptly update the catalog of approved medical device advertisements as well as the content of the approved advertisements.
The food and drug administration departments of people's governments at or above the provincial level shall order the suspension of production, sale, import, and use of medical devices. During the suspension period, no advertisements involving these medical devices may be published.
The review procedures for medical device advertisements shall be formulated jointly by the food and drug administration department under the State Council and the administration for industry and commerce under the State Council.
Chapter 5: Management of Adverse Events and Medical Device Recalls
Article 46: The State shall establish a monitoring system for adverse events involving medical devices, and promptly collect, analyze, evaluate, and control such adverse events.
Article 47: Medical device manufacturers, operators, and users shall conduct adverse event monitoring for the medical devices they produce, operate, or use. Upon discovering an adverse event or a suspected adverse event involving a medical device, they shall report it to the medical device adverse event monitoring technical institution in accordance with the regulations of the State Council’s Administration for Food and Drug Supervision.
Any organization or individual who discovers a medical device adverse event or a suspected adverse event has the right to report it to the food and drug administration department or the medical device adverse event monitoring technical institution.
Article 48: The food and drug administration department under the State Council shall strengthen the construction of a network for monitoring adverse events involving medical devices.
Medical device adverse event monitoring organizations shall strengthen the monitoring of medical device adverse event information and proactively collect such information. Upon discovering an adverse event or receiving a report of an adverse event, they shall promptly verify, investigate, and analyze the event, conduct an assessment of the adverse event, and submit recommendations for handling to the food and drug administration department and the health and family planning authorities.
Medical device adverse event monitoring agencies shall publish contact information to facilitate reporting of medical device adverse events by medical device manufacturers, operators, and users.
Article 49: The food and drug administration department shall, based on the evaluation results of medical device adverse events, promptly take control measures such as issuing warning information and ordering the suspension of production, sales, import, and use.
The food and drug administration departments of people's governments at or above the provincial level shall, in coordination with their counterparts in health and family planning authorities and other relevant departments, promptly investigate and handle adverse events involving medical devices that cause sudden, clustered serious injuries or deaths, and shall also strengthen monitoring of similar medical devices.
Article 50: Medical device manufacturers and operators, as well as users, shall cooperate with the medical device adverse event monitoring institutions and the food and drug administration departments in their investigations of medical device adverse events.
Article 51: If any of the following circumstances exist, the food and drug administration departments of provincial-level or higher people's governments shall conduct a reevaluation of medical devices that have already been registered:
(1) Changes in understanding regarding the safety and effectiveness of medical devices, based on advancements in scientific research;
(2) When the monitoring and evaluation results of medical device adverse events indicate that a medical device may have defects;
(3) Other circumstances specified by the food and drug administration department under the State Council that require reevaluation.
The re-evaluation results indicate that the registered medical devices cannot guarantee safety and efficacy. The original issuing authority will revoke the medical device registration certificates and publicly announce this decision. Medical devices whose registration certificates have been revoked may not be manufactured, imported, distributed, or used.
Article 52: If a medical device manufacturer discovers that its manufactured medical devices do not comply with mandatory standards, the technical requirements of products that have been registered or filed, or have other defects, it shall immediately cease production, notify relevant manufacturers and distributors, users, and consumers to stop business operations and use, recall medical devices already marketed and sold, take corrective measures such as repair or destruction, record the relevant details, release pertinent information, and report the medical device recall and handling situation to the food and drug administration department and the health and family planning authorities.
If a medical device distribution enterprise discovers that the medical devices it distributes fall under the circumstances specified in the preceding paragraph, it shall immediately cease distribution, notify the relevant manufacturers and suppliers, users, and consumers, and keep records of the cessation of distribution and the notification. Medical device manufacturers who believe that their products fall under the category requiring recall as stipulated in the preceding paragraph shall immediately initiate a recall.
If a medical device manufacturer or operator fails to carry out a recall or cease operations as required by this provision, the food and drug administration department may order it to conduct a recall or cease operations.
Chapter Six: Supervision and Inspection
Article 53: The food and drug administration department shall strengthen supervision and inspection of the registration, filing, manufacturing, distribution, and use activities of medical devices, and shall focus its supervision and inspection on the following matters:
(1) Does the medical device manufacturer organize production in accordance with the product technical requirements that have been registered or filed?
(2) Whether the quality management system of medical device manufacturers remains effectively operational;
(3) Whether the production and business conditions of medical device manufacturers and operators continue to meet statutory requirements.
Article 54: The food and drug administration department, during its supervision and inspection activities, shall have the following powers:
(1) Enter the site to conduct inspections and collect samples;
(2) To examine, copy, seal up, and seize relevant contracts, bills, account books, and other related materials;
(3) Seize and impound medical devices that do not meet statutory requirements, illegally used components and raw materials, as well as tools and equipment used for the illegal manufacture of medical devices;
(4) Seize premises engaged in the production and operation of medical devices in violation of the provisions of this Regulation.
When conducting supervision and inspection, the food and drug administration department shall present its law enforcement credentials and maintain the confidentiality of the inspected entity’s trade secrets.
Relevant organizations and individuals shall cooperate with the supervision and inspection conducted by the food and drug administration department and shall not conceal any relevant information.
Article 55: For medical devices that have caused harm to the human body or for which there is evidence suggesting they may pose a risk to human health, the food and drug administration department may adopt emergency control measures, including suspending production, import, distribution, and use.
Article 56: The food and drug administration department shall strengthen random inspections and tests of medical devices manufactured, marketed, and used by medical device manufacturers, operators, and users. No inspection fees or any other charges may be levied for such random inspections and tests; the costs required for these inspections shall be included in the government budget of the respective level.
The food and drug administration departments of people's governments at or above the provincial level shall promptly issue medical device quality announcements based on the results of spot checks and inspections.
Article 57: The accreditation of qualifications for medical device testing institutions shall be subject to unified management in accordance with relevant national regulations. Only testing institutions accredited jointly by the State Council’s Administration for Certification and Accreditation and the State Council’s Administration for Food and Drug Supervision may conduct testing on medical devices.
When conducting law enforcement activities, the food and drug administration department shall, if it needs to inspect medical devices, entrust the inspection to a qualified medical device testing institution and pay the associated fees.
If the party concerned disagrees with the inspection conclusion, they may, within 7 working days from the date of receipt of the inspection conclusion, choose a qualified medical device inspection agency to conduct a re-inspection. The medical device inspection agency undertaking the re-inspection shall issue its re-inspection conclusion within the time frame specified by the State Council’s Administration for Food and Drug Supervision. The re-inspection conclusion shall be the final inspection conclusion.
Article 58: For medical devices that may contain harmful substances or have undergone unauthorized changes to their design, raw materials, or manufacturing processes and thus pose safety risks, if the inspection items and methods prescribed by national and industry standards for medical devices are insufficient to conduct a proper assessment, the medical device inspection agency may supplement the inspection items and methods. The inspection conclusions obtained using these supplementary inspection items and methods, upon approval by the State Council’s Administration for Food and Drug Supervision, may serve as the basis for the Administration’s determination of the quality of medical devices.
Article 59: The food and drug administration departments of the municipal and county-level people's governments shall strengthen supervision and inspection of medical device advertisements. If they discover medical device advertisements that have been published without approval or that have altered approved advertisement content, they shall report such cases to the food and drug administration department of the people's government of the province, autonomous region, or municipality directly under the central government where they are located, which will then publicly announce such findings to the public.
The administration for industry and commerce shall, in accordance with the provisions of applicable laws and administrative regulations on advertising management, conduct supervision and inspection of medical device advertisements and investigate and deal with illegal acts. When the food and drug administration discovers instances of illegal publication of medical device advertisements, it shall submit recommendations for handling and, in accordance with relevant procedures, transfer the case to the同级 administration for industry and commerce in the local jurisdiction.
Article 60: The food and drug administration department under the State Council shall establish a unified information platform for the supervision and management of medical devices. The food and drug administration department shall, through this information platform, promptly and in accordance with the law publish daily supervisory and management information, including details on medical device licenses, filings, spot checks and inspections, and enforcement actions against illegal activities. However, it shall not disclose the commercial secrets of the parties involved.
The food and drug administration department establishes credit files for medical device registrants and filers, manufacturers and operators, and users, and increases the frequency of supervision and inspection for those with poor credit records.
Article 61: The departments responsible for food and drug supervision and administration, among others, shall publicize their contact information and accept inquiries, complaints, and reports. When receiving inquiries related to the supervision and administration of medical devices, the relevant departments shall provide timely responses. Upon receiving complaints or reports, they shall promptly verify the matters, take appropriate action, and provide a response. Records and documentation of inquiries, complaints, reports, as well as the responses, verifications, and actions taken, shall be maintained and preserved.
If a report concerning the research and development, production, distribution, or use of medical devices is verified through investigation to be true, the departments responsible for food and drug supervision and administration, among others, shall award a reward to the whistleblower.
Article 62: The department of food and drug administration under the State Council, when formulating, adjusting, or amending the catalog stipulated in these Regulations as well as standards related to the supervision and management of medical devices, shall publicly solicit comments; and shall adopt forms such as hearings and symposiums to listen to the views of experts, manufacturers and operators of medical devices, user organizations, consumers, and relevant organizations.
Chapter 7: Legal Liability
Article 63: In any of the following circumstances, the food and drug administration department under the people's government at or above the county level shall confiscate the illegal gains, illegally produced and operated medical devices, as well as tools, equipment, raw materials, and other items used in the illegal production and operation. If the value of the illegally produced and operated medical devices is less than RMB 10,000, a fine of between RMB 50,000 and RMB 100,000 shall be imposed; if the value exceeds RMB 10,000, a fine of between 10 and 20 times the value of the goods shall be imposed. In cases involving serious circumstances, applications for medical device licenses submitted by the persons concerned and their enterprises shall not be accepted for a period of five years.
(1) Manufacturing or operating Class II and Class III medical devices without obtaining the medical device registration certificate;
(2) Engaging in the production of Class II and Class III medical devices without authorization;
(3) Engaging in the business activities of Class III medical devices without permission.
In the case of any of the circumstances described in the first item of the preceding paragraph, and where the circumstances are serious, the licensing authority that originally issued the license shall revoke the medical device manufacturing license or the medical device distribution license.
Article 64: Any entity that provides false information or employs other deceptive practices to obtain licenses such as medical device registration certificates, medical device manufacturing licenses, medical device distribution licenses, or advertising approval documents shall have its previously obtained licenses revoked by the issuing authority and be fined between 50,000 and 100,000 yuan. Furthermore, within five years, applications for medical device licenses submitted by the responsible individuals and enterprises involved will not be accepted.
Anyone who forges, alters, buys, sells, leases, or lends relevant medical device licenses shall have such licenses confiscated or revoked by the original issuing authority, and any illegal gains shall be confiscated. If the illegal gains are less than 10,000 yuan, a fine of between 10,000 yuan and 30,000 yuan shall be imposed; if the illegal gains exceed 10,000 yuan, a fine of between three and five times the amount of the illegal gains shall be imposed. If the act constitutes a violation of public security administration, the public security organ shall impose administrative penalties in accordance with the law.
Article 65: Any entity that fails to file a record in accordance with the provisions of these Regulations shall be ordered by the food and drug administration department under the people's government at or above the county level to make corrections within a specified time limit. If the entity fails to make the required corrections within the prescribed time limit, its name and the names of the products involved shall be publicly announced, and the entity may be fined up to RMB 10,000.
If false information is provided during the filing process, the food and drug administration department of the people's government at or above the county level shall publicly announce the name of the filing entity and the product name. In cases of serious violations, the directly responsible personnel shall be prohibited from engaging in the production and operation of medical devices for a period of five years.
Article 66: In any of the following circumstances, the food and drug administration department under the people's government at or above the county level shall order rectification and confiscate the medical devices that have been illegally manufactured, marketed, or used. If the value of the illegally manufactured, marketed, or used medical devices is less than RMB 10,000, a fine of between RMB 20,000 and RMB 50,000 shall also be imposed; if the value exceeds RMB 10,000, a fine ranging from five to ten times the value of the devices shall be imposed. In cases of serious violations, the department shall order suspension of production and business operations, and may even revoke the medical device registration certificate, medical device manufacturing license, or medical device distribution license issued by the original licensing authority.
(1) Manufacturing, marketing, or using medical devices that do not comply with mandatory standards or with the product technical requirements that have been registered or filed;
(2) Medical device manufacturers fail to organize production in accordance with the technical requirements of products that have been registered or filed, or fail to establish and maintain an effective quality management system as required by these Regulations;
(3) Operating or using medical devices that lack valid certification documents, are expired, invalid, or obsolete, or using medical devices that have not been legally registered;
(4) After being ordered by the food and drug administration department to carry out a recall or cease operations in accordance with the provisions of this regulation, the entity still refuses to recall or cease operations of the medical devices;
(5) Entrusting the production of medical devices to enterprises that do not meet the conditions stipulated in these Regulations, or failing to manage the production activities of the entrusted party.
Article 67: In any of the following circumstances, the food and drug administration department of the people's government at or above the county level shall order rectification and impose a fine of between 10,000 yuan and 30,000 yuan; in cases of serious violations, the department shall order suspension of production and business operations, up to and including revocation of the medical device manufacturing license and the medical device distribution license by the original issuing authority:
(1) If the production conditions of a medical device manufacturer change and no longer meet the requirements of the medical device quality management system, and the manufacturer fails to make rectifications, cease production, or report as required under these Regulations;
(2) Medical devices whose instructions for use and labels do not comply with the provisions of these Regulations;
(3) Failing to transport or store medical devices in accordance with the requirements indicated on the instructions and labels of the medical devices;
(4) Transferring medical devices in use that are expired, invalidated, phased out, or have failed inspection.
Article 68: In any of the following circumstances, the food and drug administration department and the health and family planning authority at or above the county level shall, according to their respective responsibilities, order rectification and issue a warning; if the party concerned refuses to make corrections, a fine of between 5,000 yuan and 20,000 yuan shall be imposed. In cases of serious violations, the authorities shall order suspension of production and business operations, and may even revoke the medical device manufacturing license and/or medical device distribution license issued by the original licensing authority.
(1) Medical device manufacturers that have failed to submit self-inspection reports on their quality management systems as required;
(2) Medical device operators and users that have failed to establish and implement a medical device incoming inspection record system in accordance with the provisions of this Regulation;
(3) Business operators engaged in wholesale distribution of Class II and Class III medical devices, as well as retail sales of Class III medical devices, who have failed to establish and implement a sales record-keeping system in accordance with the provisions of these Regulations;
(4) For medical devices that are reused, if the medical device user fails to handle them in accordance with the regulations on disinfection and management;
(5) Medical device users who reuse single-use medical devices or fail to destroy used single-use medical devices in accordance with the prescribed regulations;
(6) For medical devices that require regular inspection, testing, calibration, maintenance, and servicing, the medical device user has failed to conduct such inspections, tests, calibrations, maintenance, and servicing in accordance with the product instructions and to keep proper records thereof; nor has it promptly analyzed and evaluated the results to ensure that the medical devices remain in good working condition.
(7) Medical device users have failed to properly preserve the original documentation for purchased Class III medical devices, or have failed to record information on large-scale medical devices as well as implantable and interventional medical devices in medical records and other relevant documentation as required.
(8) If a medical device user discovers that the medical devices it uses pose safety hazards but fails to immediately stop using them, notify for repair, or continues to use medical devices that, even after repair, still fail to meet safety standards;
(9) Medical device manufacturers and operators, as well as users, who fail to carry out medical device adverse event monitoring in accordance with the provisions of this Regulation, fail to report adverse events as required, or fail to cooperate with investigations into adverse events conducted by medical device adverse event monitoring agencies or food and drug administration departments.
Article 69: Any entity that conducts clinical trials of medical devices in violation of the provisions of these Regulations shall be ordered by the food and drug administration department under the people's government at or above the county level to make corrections or immediately cease the clinical trials, and may be fined up to RMB 50,000. If serious consequences are caused, the directly responsible supervisors and other persons directly liable shall be subject to disciplinary actions including demotion, removal from office, or dismissal in accordance with law. In the case of an entity holding qualification as a medical device clinical trial institution, the competent authority that granted such qualification shall revoke its qualification, and the entity shall not have its qualification application accepted for a period of five years.
If a clinical trial institution for medical devices issues a false report, the competent authority that granted it the qualification shall revoke its qualification as a clinical trial institution for medical devices and shall not accept its application for qualification recognition for a period of 10 years. The food and drug administration department of the people's government at or above the county level shall impose a fine ranging from 50,000 to 100,000 yuan. Any illegal gains shall be confiscated. The directly responsible persons in charge and other persons directly liable shall be subject to disciplinary action, including removal from office or dismissal, in accordance with the law.
Article 70: If a medical device testing institution issues a false testing report, the competent authority that granted it the qualification shall revoke its testing qualification and shall not accept its application for qualification accreditation for a period of 10 years. The institution shall also be fined between 50,000 yuan and 100,000 yuan. Any illegal gains shall be confiscated. The directly responsible principal and other persons directly liable shall be subject to disciplinary action in accordance with the law, including removal from office or dismissal. Those who have been dismissed shall be prohibited from engaging in medical device testing work for a period of 10 years from the date on which the disciplinary decision is made.
Article 71: Any violation of the provisions of these Regulations involving the publication of medical device advertisements without obtaining the required approval documents, publishing medical device advertisements without first verifying the authenticity of the approval documents, or publishing medical device advertisements whose content does not conform to the approved documents shall be subject to penalties imposed by the administrative department for industry and commerce in accordance with the relevant laws and administrative regulations governing advertising.
Any entity that alters the content of an approved medical device advertisement shall have its advertising approval document revoked by the original issuing authority, and its application for advertising approval will not be accepted for a period of two years.
For those who publish false advertisements for medical devices, the food and drug administration departments of provincial-level or higher people's governments shall order a suspension of sales of the medical device and publicly announce this decision. If the medical device continues to be sold, the food and drug administration departments of county-level or higher people's governments shall confiscate the illegally sold medical devices and impose a fine ranging from 20,000 yuan to 50,000 yuan.
Article 72: If a medical device technical review institution or a medical device adverse event monitoring institution fails to fulfill its duties as prescribed in these Regulations, resulting in significant errors in the review and monitoring processes, the food and drug administration department of the people's government at or above the county level shall order it to make corrections, issue a public criticism, and give a warning. In cases where serious consequences have resulted, the directly responsible principal personnel and other persons directly liable shall be subject to disciplinary actions—including demotion, removal from office, or dismissal—in accordance with the law.
Article 73: The food and drug administration authorities and their staff shall exercise their administrative penalty powers strictly in accordance with the types and ranges of penalties prescribed in these Regulations, taking into account the nature and specific circumstances of the illegal acts. The specific measures shall be formulated by the food and drug administration authority under the State Council.
Article 74: In violation of the provisions of these Regulations, if the food and drug administration department or other relevant departments of the people's governments at or above the county level fail to perform their duties in the supervision and management of medical devices, or if they abuse their powers, neglect their duties, or engage in corruption and malpractice, the supervisory authority or the appointing and removing authority shall, in accordance with law, impose disciplinary measures such as a warning, a record of demerit, or a serious record of demerit on the directly responsible leading personnel and other persons directly liable. If serious consequences are caused, they shall be subject to disciplinary measures including demotion, removal from office, or dismissal.
Article 75: Any violation of the provisions of these Regulations that constitutes a crime shall be subject to criminal liability in accordance with the law; and any resulting personal injury, property damage, or other harm shall give rise to compensation liability as prescribed by law.
Chapter VIII: Supplementary Provisions
Article 76: The meanings of the terms used in these Regulations are as follows:
Medical devices refer to instruments, equipment, apparatuses, in vitro diagnostic reagents and calibrators, materials, and other similar or related articles that are intended for direct or indirect use on the human body, including any necessary computer software. Their intended effects are primarily achieved through physical means rather than pharmacological, immunological, or metabolic mechanisms—or although these mechanisms may be involved, they play only a supporting role. The purposes of such devices are:
(1) Diagnosis, prevention, monitoring, treatment, or alleviation of diseases;
(2) Diagnosis, monitoring, treatment, relief, or functional compensation for injuries;
(3) Examination, substitution, regulation, or support of physiological structures or physiological processes;
(4) Support or maintenance of life;
(5) Pregnancy control;
(6) Providing information for medical or diagnostic purposes by examining samples derived from the human body.
A medical device user refers to an organization that uses medical devices to provide medical and other technical services to others. This includes medical institutions that have obtained a medical institution practice license, family planning service institutions that have obtained a family planning service institution practice license, as well as blood banks, single-donor plasma collection centers, rehabilitation assistive device fitting institutions, and other entities that, in accordance with the law, are not required to obtain a medical institution practice license.
Article 77: Fees may be charged for the registration of medical device products. The specific fee items and standards shall be formulated by the financial and pricing authorities under the State Council in accordance with relevant national regulations.
Article 78: The administrative measures for non-profit contraceptive medical devices, as well as the administrative measures for medical devices developed by medical and health institutions in response to public health emergencies, shall be formulated jointly by the State Council’s Food and Drug Administration and the State Council’s Department of Health and Family Planning.
The administrative measures for medical devices used in traditional Chinese medicine shall be formulated by the food and drug administration department under the State Council, in conjunction with the traditional Chinese medicine administration department under the State Council, in accordance with the provisions of these Regulations. The scope of rehabilitation assistive devices and their administrative measures shall be formulated by the food and drug administration department under the State Council, in conjunction with the civil affairs department under the State Council, in accordance with the provisions of these Regulations.
Article 79: The supervision and management of the use of medical devices in the military shall be organized and implemented by the military health authorities in accordance with these Regulations and relevant military provisions.
Article 80: These Regulations shall come into force on June 1, 2014.
Previous: